Fundz

Vascular Perfusion Solutions reported raising $147 Million in an initial SEC Form D filing, from an offering of $344 Million

PRIVATEMay 30, 2025

Amount Raised

$147 Million

$147 Million sold, per SEC Form D (first sale May 16, 2025)

Round Type

Venture

San AntonioBiotechnology

Who to call at Vascular Perfusion Solutions, and when

A new round usually means Vascular Perfusion Solutions is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vascular Perfusion Solutions raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vascular Perfusion Solutions, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vascular Perfusion Solutions. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vascular Perfusion Solutions

Location

8647 WURZBACH ROAD, SUITE J-200

San Antonio, Texas, United States

About

Vascular Perfusion Solutions (VPS), a Texas-based early-stage Medtech company, is revolutionizing organ transplantation with a focus on simplicity, ease of use, and accessibility in price through our flagship product, the VP.S ENCORE®, a hypothermic machine perfusion device for prolonged cardiac graft preservation. This innovative device represents a groundbreaking advancement in heart preservation technology, surpassing conventional methods such as the ice-cooler. It has gained FDA breakthrough device designation in 2021 and undergone successful preclinical testing on over 100 hearts, including ovine, porcine, and human hearts donated for research.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vascular Perfusion Solutions raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsLeonid B., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Vascular Perfusion Solutions's next move

See what Strategic adds

Vascular Perfusion Solutions raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.